The Hardest Disease Transmission Type to Eradicate Is Vector Transmission Discussion

I’m trying to study for my Health & Medical course and I need some help to understand this question.

Last week we talked about direct transmission, indirect transmission, vector transmission, animal to human transmission, and human-to-human only transmission. Which of these disease transmission types would be the hardest to eradicate? The easiest? Why?

The 1990s witnessed one of the most successful programmes to eradicate malaria by tackling its vector, the Anopheles mosquito. Its main component was the release of sterilised male mosquitoes into the environment, which competed with wild ones for the available females. By repeating this every year with ever-increasing numbers of sterilised flies, health officials from the World Health Organization (WHO) and various countries hoped to eradicate the mosquito and thus malaria. In some parts of the world, this method indeed worked; southern Europe and large areas of Asia, North and Central America and Africa became virtually malaria free. But while Europe has remained so, the mosquitoes and the diseases they transmit have come back with a vengeance in many areas around the world.

The latest data released in August 2001 show that there are now between 700 000 and 2.7 million deaths each year from malaria, 75% of which are African children. According to the Multilateral Initiative on Malaria, this is a higher mortality rate than the yearly toll of AIDS in Africa. Besides the fatalities, between 400 and 900 million acute episodes of fever occur in children under the age of five which can slow brain development and retard cognitive abilities. Anthony James, a geneticist at the University of California in Irvine, refers to malaria as ‘the most difficult vector-borne disease to control’.

Controversy abounds in the scientific community about the causes of the resurgence of these and other vector-borne infectious diseases such as leishmaniasis, yellow fever, encephalitis and dengue fever. Theories vary from global warming to the discontinuation of the use of DDT, but as Paul Reiter from the Centers for Disease Control in Atlanta, Georgia, remarked ‘Public concern should focus on ways to deal with the realities of malaria transmission, rather than on the weather’.

A number of scientists are responding to Reiter’s challenge by focusing on genetics in order to analyse and ultimately modify the parasites or their vectors. ‘Genetic engineering complements the other modalities of improved public health care and vaccine, drug and pesticide development, and is not aimed at replacing them’, said Bruce Christensen, chair of the Department of Animal Health and Biomedical Sciences at the University of Wisconsin in Madison. ‘It is unlikely that any single strategy will be successful for the complete control of malaria’, James agrees. ‘We anticipate that an integrated approach that includes bed nets, parasite-resistant mosquitoes and vaccines will ultimately control or eliminate the disease if the role of each component intervention method is optimised for a specific region of transmission’, he said.

Indeed, developing vaccines against the protozoan causing malaria and leishmaniasis has been extremely challenging, because the pathogens have developed various ways to evade the patient’s immune system. But a number of groups are finally making headway. Giampetro Corradin of the University of Lausanne in Switzerland recently stated that his synthetic malaria vaccine, derived from a surface protein of the Plasmodium falciparum parasite, was the first to produce both strong B- and T-cell responses in early-stage human testing. Corradin plans to vary the peptide sequence in order to make the vaccine effective against several strains of the organism.

Another group is investigating the ability of P. falciparum to suppress an immune response, also with the goal of developing a vaccine against malaria. Magdalena Plebanski of the Austin Research Institute in Melbourne, Australia discovered that Plasmodium uses an ‘altered peptide ligand’ (APL) antagonism to dampen the cell-mediated immune response. It specifically disarms the protective T cells that ordinarily would kill infected cells. Plebanski’s team has produced synthetic APLs that are agonists for T-cell activation, counteracting the antagonistic APL peptide variants found in Plasmodium. Mice infected with a mouse version of malaria that had been stimulated with two antagonistic APLs responded to an agonistic APL and had an immune reaction against all three. The team now plans to move into human trials within a year using agonistic peptides that they hope will reactivate the T-cell response in humans.

Researchers at the National Institute of Allergy and Infectious Disease (NIAID) achieved success in finding a vaccine against Leishmania, a protozoa affecting 12 million people in South and Central America, Africa and the Middle East—albeit a somewhat unusual one. ‘Rather than targeting the parasite, as is typical, our researchers produced a vaccine to the saliva of the insect that transmits the parasite. This approach could potentially be used to develop vaccines for other insect- or tick-borne diseases’, NIAID director Anthony Fauci said. Early in August 2001, NIAID announced that a vaccine against a component in the saliva of sand flies—the insects transmitting leishmaniasis—protects against the pathogen. Head researcher Jose Ribeiro has focused on the chemistry of blood-feeding insects’ saliva for the past three decades because of its effects on immunomodulation of the host, and demonstrated that animals immunised with sand fly saliva often resist infection when challenged with parasites or when bitten by a Leishmania-carrying bug.

The new study, published in the Journal of Experimental Medicine, used that information to produce a DNA vaccine encoding a saliva protein found in sand flies infected with Leishmania. Mice immunised with the vaccine contracted a much milder version of the disease than those that were unvaccinated. The researchers will next test dogs and monkeys, as well as examine other strains of Leishmania and sand flies in order to produce a vaccine for other types of the disease. They are also studying humans exposed to the disease to determine which particular components of saliva could be protective for them. ‘Different sand fly species transmit different Leishmania species. If anti-saliva vaccines are to work in humans, they will have to be specifically engineered for the problem insects of each particular region’, Ribeiro said.

Other researchers think that it could be worthwhile to use genetics and target the vector rather than the pathogen. ‘[The malaria mosquito] is an exquisitely complex host that supports a complicated lifecycle’, Frank Collins, Professor of biological sciences at the University of Notre Dame in South Bend, Indiana, said, ‘There are many points where it may be possible to genetically interfere with this lifecycle’.

Indeed, in August 2001 NIAID announced a US$ 9 million award to Celera Genomics to expand the efforts to map the genome of Anopheles gambia, the malaria-transmitting mosquito, and to make the results freely available to the scientific community. Celera and an international consortium established two years ago, including the WHO, the Pasteur Institute, the European Molecular Biology Laboratory and others, will then analyse the Anopheles genome together with that of the human and the nearly completed sequence of P. falciparum.

The Hardest Disease Transmission Type to Eradicate Is Vector Transmission Discussion

Important information for writing discussion questions and participation

Welcome to class

Hello class and welcome to the class and I will be your instructor for this course. This is a -week course and requires a lot of time commitment, organization, and a high level of dedication. Please use the class syllabus to guide you through all the assignments required for the course. I have also attached the classroom policies to this announcement to know your expectations for this course. Please review this document carefully and ask me any questions if you do. You could email me at any time or send me a message via the “message” icon in halo if you need to contact me. I check my email regularly, so you should get a response within 24 hours. If you have not heard from me within 24 hours and need to contact me urgently, please send a follow up text to

I strongly encourage that you do not wait until the very last minute to complete your assignments. Your assignments in weeks 4 and 5 require early planning as you would need to present a teaching plan and interview a community health provider. I advise you look at the requirements for these assignments at the beginning of the course and plan accordingly. I have posted the YouTube link that explains all the class assignments in detail. It is required that you watch this 32-minute video as the assignments from week 3 through 5 require that you follow the instructions to the letter to succeed. Failure to complete these assignments according to instructions might lead to a zero. After watching the video, please schedule a one-on-one with me to discuss your topic for your project by the second week of class. Use this link to schedule a 15-minute session. Please, call me at the time of your appointment on my number. Please note that I will NOT call you.

Please, be advised I do NOT accept any assignments by email. If you are having technical issues with uploading an assignment, contact the technical department and inform me of the issue. If you have any issues that would prevent you from getting your assignments to me by the deadline, please inform me to request a possible extension. Note that working fulltime or overtime is no excuse for late assignments. There is a 5%-point deduction for every day your assignment is late. This only applies to approved extensions. Late assignments will not be accepted.

If you think you would be needing accommodations due to any reasons, please contact the appropriate department to request accommodations.

Plagiarism is highly prohibited. Please ensure you are citing your sources correctly using APA 7th edition. All assignments including discussion posts should be formatted in APA with the appropriate spacing, font, margin, and indents. Any papers not well formatted would be returned back to you, hence, I advise you review APA formatting style. I have attached a sample paper in APA format and will also post sample discussion responses in subsequent announcements.

Your initial discussion post should be a minimum of 200 words and response posts should be a minimum of 150 words. Be advised that I grade based on quality and not necessarily the number of words you post. A minimum of TWO references should be used for your initial post. For your response post, you do not need references as personal experiences would count as response posts. If you however cite anything from the literature for your response post, it is required that you cite your reference. You should include a minimum of THREE references for papers in this course. Please note that references should be no more than 5 years old except recommended as a resource for the class. Furthermore, for each discussion board question, you need ONE initial substantive response and TWO substantive responses to either your classmates or your instructor for a total of THREE responses. There are TWO discussion questions each week, hence, you need a total minimum of SIX discussion posts for each week. I usually post a discussion question each week. You could also respond to these as it would count towards your required SIX discussion posts for the week.

I understand this is a lot of information to cover in 5 weeks, however, the Bible says in Philippians 4:13 that we can do all things through Christ that strengthens us. Even in times like this, we are encouraged by God’s word that we have that ability in us to succeed with His strength. I pray that each and every one of you receives strength for this course and life generally as we navigate through this pandemic that is shaking our world today. Relax and enjoy the course!

Hi Class,

Please read through the following information on writing a Discussion question response and participation posts.

Contact me if you have any questions.

Important information on Writing a Discussion Question

• Your response needs to be a minimum of 150 words (not including your list of references)
• There needs to be at least TWO references with ONE being a peer reviewed professional journal article.
• Include in-text citations in your response
• Do not include quotes—instead summarize and paraphrase the information
• Follow APA-7th edition
• Points will be deducted if the above is not followed

Participation –replies to your classmates or instructor

• A minimum of 6 responses per week, on at least 3 days of the week.
• Each response needs at least ONE reference with citations—best if it is a peer reviewed journal article
• Each response needs to be at least 75 words in length (does not include your list of references)
• Responses need to be substantive by bringing information to the discussion or further enhance the discussion. Responses of “I agree” or “great post” does not count for the word count.
• Follow APA 7th edition
• Points will be deducted if the above is not followed

• Remember to use and follow APA-7th edition for all weekly assignments, discussion questions, and participation points.
• Here are some helpful links
• The is a great resource